Empagliflozin as add-on to metformin in people with Type 2 diabetes

Merker, L.; Haering, H-U.; Christiansen, A. V.; Roux, F.; Salsali, A.; Kim, G.; Meinicke, T.; Woerle, H. J.; Broedl, U. C.

dc.contributor.author	Häring, Hans-Ulrich
dc.date.accessioned	2016-06-09T15:39:21Z
dc.date.available	2016-06-09T15:39:21Z
dc.date.issued	2015
dc.identifier.issn	1464-5491
dc.identifier.uri	http://hdl.handle.net/10900/70444
dc.language.iso	en	de_DE
dc.publisher	Wiley - Blackwell	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/dme.12814	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Empagliflozin as add-on to metformin in people with Type 2 diabetes	de_DE
dc.type	Article	de_DE
utue.quellen.id	20160427062602_00190
utue.publikation.seiten	1555-1567	de_DE
utue.personen.roh	Merker, L.
utue.personen.roh	Haering, H-U.
utue.personen.roh	Christiansen, A. V.
utue.personen.roh	Roux, F.
utue.personen.roh	Salsali, A.
utue.personen.roh	Kim, G.
utue.personen.roh	Meinicke, T.
utue.personen.roh	Woerle, H. J.
utue.personen.roh	Broedl, U. C.
dcterms.isPartOf.ZSTitelID	Diabetic Medicine	de_DE
dcterms.isPartOf.ZS-Issue	12	de_DE
dcterms.isPartOf.ZS-Volume	32	de_DE